Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Masuda

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
International Journal of Nanomedicine|March 1, 2017
An in vivo mechanism for the reduced peripheral neurotoxicity of NK105: a paclitaxel-incorporating polymeric micellar nanoparticle formulationIwao Nakamura, Eiji Ichimura, Rika Goda, et al.
Cancer Research|January 10, 2002
Identification of frequent G(2) checkpoint impairment and a homozygous deletion of 14-3-3epsilon at 17p13.3 in small cell lung cancersHiroyuki Konishi, Taku Nakagawa, Tomoko Harano, et al.
Lung Cancer (Amsterdam, Netherlands)|September 27, 2003
The sensitivity of lung cancer cell lines to the EGFR-selective tyrosine kinase inhibitor ZD1839 ('Iressa') is not related to the expression of EGFR or HER-2 or to K-ras gene statusTakeshi Suzuki, Taku Nakagawa, Hideki Endo, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|October 2, 2002
Increased K-ras protein and activity in mouse and human lung epithelial cells at confluenceWafa Kammouni, Gayatri Ramakrishna, Gunamani Sithanandam, et al.
Oncogene|April 26, 2002
Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivoKatsumi Koshikawa, Hirotaka Osada, Ken-Ichi Kozaki, et al.
Cancer Research|July 17, 2004
Identification of decatenation G2 checkpoint impairment independently of DNA damage G2 checkpoint in human lung cancer cell linesTaku Nakagawa, Yoji Hayashita, Ken Maeno, et al.
Molecular Psychiatry|June 13, 2018
Ant1 mutant mice bridge the mitochondrial and serotonergic dysfunctions in bipolar disorderTomoaki M Kato, Mie Kubota-Sakashita, Noriko Fujimori-Tonou, et al.
Cell Reports|August 28, 2014
RacGAP α2-chimaerin function in development adjusts cognitive ability in adulthoodRyohei Iwata, Kazutaka Ohi, Yuki Kobayashi, et al.
The American Journal of Pathology|December 26, 2003
K-ras gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cells via Akt activation: possible contribution to non-invasive expansion of lung adenocarcinomaKoji Okudela, Hiroyuki Hayashi, Takaaki Ito, et al.
Toxicology and Applied Pharmacology|August 14, 2003
Gene expression dose-response changes in microarrays after exposure of human peripheral lung epithelial cells to nickel(II)Robert Y S Cheng, Ailian Zhao, W Gregory Alvord, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
International Journal of Nanomedicine|March 1, 2017
An in vivo mechanism for the reduced peripheral neurotoxicity of NK105: a paclitaxel-incorporating polymeric micellar nanoparticle formulationIwao Nakamura, Eiji Ichimura, Rika Goda, et al.
Cancer Research|January 10, 2002
Identification of frequent G(2) checkpoint impairment and a homozygous deletion of 14-3-3epsilon at 17p13.3 in small cell lung cancersHiroyuki Konishi, Taku Nakagawa, Tomoko Harano, et al.
Lung Cancer (Amsterdam, Netherlands)|September 27, 2003
The sensitivity of lung cancer cell lines to the EGFR-selective tyrosine kinase inhibitor ZD1839 ('Iressa') is not related to the expression of EGFR or HER-2 or to K-ras gene statusTakeshi Suzuki, Taku Nakagawa, Hideki Endo, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|October 2, 2002
Increased K-ras protein and activity in mouse and human lung epithelial cells at confluenceWafa Kammouni, Gayatri Ramakrishna, Gunamani Sithanandam, et al.
Oncogene|April 26, 2002
Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivoKatsumi Koshikawa, Hirotaka Osada, Ken-Ichi Kozaki, et al.
Cancer Research|July 17, 2004
Identification of decatenation G2 checkpoint impairment independently of DNA damage G2 checkpoint in human lung cancer cell linesTaku Nakagawa, Yoji Hayashita, Ken Maeno, et al.
Molecular Psychiatry|June 13, 2018
Ant1 mutant mice bridge the mitochondrial and serotonergic dysfunctions in bipolar disorderTomoaki M Kato, Mie Kubota-Sakashita, Noriko Fujimori-Tonou, et al.
Cell Reports|August 28, 2014
RacGAP α2-chimaerin function in development adjusts cognitive ability in adulthoodRyohei Iwata, Kazutaka Ohi, Yuki Kobayashi, et al.
The American Journal of Pathology|December 26, 2003
K-ras gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cells via Akt activation: possible contribution to non-invasive expansion of lung adenocarcinomaKoji Okudela, Hiroyuki Hayashi, Takaaki Ito, et al.
Toxicology and Applied Pharmacology|August 14, 2003
Gene expression dose-response changes in microarrays after exposure of human peripheral lung epithelial cells to nickel(II)Robert Y S Cheng, Ailian Zhao, W Gregory Alvord, et al.
Pageof 4